Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-08 5:15 PM View:  | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 01-Apr-08 | Grant | 3,528 | $2.48 | $8,749.44 | 100% 0 to 3.53K | (92%) |
| 23-Jan-08 8:41 PM View: | Carter Kenneth C President and CEO Director | Avalon Pharmaceuticals, Inc. (AVRX) | 23-Jan-08 | Market Purchase | 4,832 | $2.58 | $12,484.80 | 21% 22.79K to 27.63K | (93%) |
| 23-Jan-08 8:41 PM View: | Carter Kenneth C President and CEO Director | Avalon Pharmaceuticals, Inc. (AVRX) | 17-Jan-08 | Market Sale | 2,032 | $2.53 | $5,145.40 | (7%) 27.63K to 25.59K | 92% |
| 04-Jan-08 1:32 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Jan-08 | Grant | 2,635 | $3.32 | $8,748.20 | 100% 0 to 2.63K | (94%) |
| 04-Jan-08 4:46 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Jan-08 | Grant | 816 | $3.32 | $2,709.12 | 4% 21.98K to 22.8K | (94%) |
| 02-Oct-07 7:38 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 01-Oct-07 | Grant | 1,477 | $5.50 | $8,123.50 | 7% 20.5K to 21.98K | (97%) |
| 02-Oct-07 4:19 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 01-Oct-07 | Grant | 1,591 | $5.50 | $8,750.50 | 100% 0 to 1.59K | (97%) |
| 05-Jul-07 3:19 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Jul-07 | Grant | 3,243 | $4.24 | $13,750.30 | 19% 17.26K to 20.5K | (96%) |
| 05-Jul-07 9:52 AM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Jul-07 | Grant | 1,931 | $4.24 | $8,187.44 | 100% 0 to 1.93K | (96%) |
| 05-Jul-07 9:53 AM View: | Whitaker Raymond J Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Jul-07 | Grant | 1,658 | $4.24 | $7,029.92 | 100% 0 to 1.66K | (96%) |
| 03-Apr-07 5:52 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Apr-07 | Grant | 3,046 | $4.72 | $14,377.10 | 21% 14.21K to 17.26K | (96%) |
| 04-Apr-07 5:00 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Apr-07 | Grant | 1,721 | $4.72 | $8,123.12 | < 1% 601.16K to 602.88K | (96%) |
| 04-Apr-07 5:02 PM View: | Whitaker Raymond J Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Apr-07 | Grant | 1,986 | $4.72 | $9,373.92 | < 1% 766.56K to 768.54K | (96%) |
| 05-Jan-07 1:56 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 03-Jan-07 | Grant | 1,512 | $3.72 | $5,624.64 | < 1% 599.64K to 601.16K | (95%) |
| 05-Jan-07 1:56 PM View: | Whitaker Raymond J Director | Avalon Pharmaceuticals, Inc. (AVRX) | 03-Jan-07 | Grant | 1,848 | $3.72 | $6,874.56 | < 1% 764.71K to 766.56K | (95%) |
| 08-Jan-07 6:11 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 03-Jan-07 | Grant | 3,192 | $3.72 | $11,874.20 | 100% 0 to 3.19K | (95%) |
| 04-Oct-06 8:43 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Oct-06 | Grant | 4,621 | $2.57 | $11,876.00 | 72% 6.4K to 11.02K | (93%) |
| 04-Oct-06 6:08 PM View: | Whitaker Raymond J Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Oct-06 | Grant | 2,675 | $2.57 | $6,874.75 | < 1% 762.03K to 764.71K | (93%) |
| 04-Oct-06 6:09 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 02-Oct-06 | Grant | 2,189 | $2.57 | $5,625.73 | < 1% 597.46K to 599.64K | (93%) |
| 31-Aug-06 11:52 AM View: | Carter Kenneth C President and CEO Director | Avalon Pharmaceuticals, Inc. (AVRX) | 30-Aug-06 | Market Purchase | 3,000 | $2.99 | $8,970.00 | 12% 24.63K to 27.63K | (94%) |
| 30-Aug-06 4:27 PM View: | Hamilton J Michael Chief Medical Officer | Avalon Pharmaceuticals, Inc. (AVRX) | 28-Aug-06 | Market Purchase | 2,500 | $3.09 | $7,725.00 | 1250% 0.2K to 2.7K | (94%) |
| 24-Aug-06 5:00 PM View: | Carter Kenneth C President and CEO Director | Avalon Pharmaceuticals, Inc. (AVRX) | 22-Aug-06 | Market Purchase | 2,000 | $3.27 | $6,541.00 | 9% 22.63K to 24.63K | (94%) |
| 11-Jul-06 5:40 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 07-Jul-06 | Grant | 3,503 | $3.39 | $11,875.20 | 100% 0 to 3.5K | |
| 07-Jul-06 11:54 AM View: | Whitaker Raymond J Director | Avalon Pharmaceuticals, Inc. (AVRX) | 06-Jul-06 | Grant | 2,028 | $3.39 | $6,874.92 | 100% 0 to 2.03K | (94%) |
| 07-Jul-06 11:56 AM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 06-Jul-06 | Grant | 1,659 | $3.39 | $5,624.01 | 100% 0 to 1.66K | (94%) |
| 04-Apr-06 4:08 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 03-Apr-06 | Grant | 1,260 | $4.96 | $6,249.60 | 100% 0 to 1.26K | (96%) |
| 05-Apr-06 9:47 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 03-Apr-06 | Grant | 2,898 | $4.96 | $14,374.10 | 100% 0 to 2.9K | (96%) |
| 05-Jan-06 1:01 PM View: | Whitaker Raymond J Director | Avalon Pharmaceuticals, Inc. (AVRX) | 03-Jan-06 | Grant | 1,482 | $4.64 | $6,876.48 | 100% 0 to 1.48K | (96%) |
| 05-Jan-06 1:02 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 03-Jan-06 | Grant | 1,347 | $4.64 | $6,250.08 | 100% 0 to 1.35K | (96%) |
| 05-Jan-06 8:57 PM View: | Walton Alan Director | Avalon Pharmaceuticals, Inc. (AVRX) | 03-Jan-06 | Grant | 3,098 | $4.64 | $14,374.70 | 100% 0 to 3.1K | (96%) |
| 06-Oct-05 6:16 PM View: | Oxford Bioscience Partners ... 10% Owner | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Conversion | 457,946 | -- | -- | 523% 87.5K to 545.45K | |
| 06-Oct-05 5:04 PM View: | Gimv Nv 10% Owner | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Conversion | 710,207 | $1.21 | $861,367.00 | 87% 813.2K to 1.52M | |
| 06-Oct-05 5:06 PM View: | Whitaker Raymond J Director | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Conversion Duplicate | 553,238 | $1.01 | $558,999.00 | 115% 480.52K to 1.03M | |
| 06-Oct-05 6:16 PM View: | Oxford Bioscience Partners ... 10% Owner | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Purchase | 36,205 | $10.50 | $380,152.00 | 4% 804.93K to 841.14K | |
| 06-Oct-05 5:05 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Purchase | 136,000 | $10.50 | $1,428,000.00 | 13% 1.01M to 1.15M | |
| 06-Oct-05 6:16 PM View: | Oxford Bioscience Partners ... 10% Owner | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Conversion | 114,293 | -- | -- | 21% 545.45K to 659.74K | |
| 06-Oct-05 5:05 PM View: | Lorimier Bradley G Director | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Conversion | 4,880 | $1.01 | $4,935.00 | 122% 4.0K to 8.88K | |
| 18-Oct-05 3:57 PM View: | Euclidsr Biotechnology Part... Director | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Conversion | 553,238 | $1.01 | $558,999.00 | 61% 907.8K to 1.46M | |
| 06-Oct-05 5:03 PM View: | Beneden Patrick van Director 10% Owner | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Purchase Duplicate | 181,400 | $10.50 | $1,904,700.00 | 12% 1.52M to 1.7M | |
| 06-Oct-05 5:06 PM View: | Whitaker Raymond J Director | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Purchase Duplicate | 203,900 | $10.50 | $2,140,950.00 | 20% 1.03M to 1.24M | |
| 06-Oct-05 5:03 PM View: | Beneden Patrick van Director 10% Owner | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Conversion Duplicate | 710,207 | $1.21 | $861,367.00 | 87% 813.2K to 1.52M | |
| 06-Oct-05 5:05 PM View: | Royston Ivor Director | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Conversion | 457,190 | $1.17 | $534,859.00 | 82% 557.46K to 1.01M | |
| 06-Oct-05 6:16 PM View: | Oxford Bioscience Partners ... 10% Owner | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Purchase | 145,195 | $10.50 | $1,524,550.00 | 22% 659.74K to 804.93K | |
| 06-Oct-05 5:04 PM View: | Gimv Nv 10% Owner | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Purchase | 181,400 | $10.50 | $1,904,700.00 | 12% 1.52M to 1.7M | |
| 18-Oct-05 3:57 PM View: | Euclidsr Biotechnology Part... Director | Avalon Pharmaceuticals, Inc. (AVRX) | 04-Oct-05 | Purchase | 203,900 | $10.50 | $2,140,950.00 | 14% 1.46M to 1.66M |
